Position in AMGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$809,958
+$242,454 QoQ
Shares Held
2,302
+14.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026First Affirmative Financial Network holds $11,800,477 across 12 Drug Manufacturers - General names. AMGN ranks #7 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
12,575 | $1,920,831 | |
| 2 | JNJ |
Johnson & Johnson
|
7,524 | $1,839,166 | |
| 3 | LLY |
ELI LILLY & Co
|
1,848 | $1,699,734 | |
| 4 | AZN |
Astrazeneca PLC
|
7,477 | $1,474,613 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,609 | $1,276,156 | |
| 6 | ABBV |
AbbVie Inc.
|
5,527 | $1,202,067 | |
| 7 | AMGN |
Amgen Inc
This page
|
2,302 | $809,958 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,735 | $520,546 |
All Filings in AMGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $809,958 | 2,302 | Shares | Sole | 2026-05-11 | |
| 2025-09-30 | $567,504 | 2,011 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $566,517 | 2,029 | Shares | Sole | 2025-11-20 | |
| 2025-03-31 | $644,596 | 2,069 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $903,638 | 3,467 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,023,338 | 3,176 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $433,993 | 1,389 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $357,958 | 1,259 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $340,727 | 1,183 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $249,409 | 928 | Shares | Sole | 2023-10-16 | |
| No filing history on record for this holder in this stock. | ||||||